Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.
Nathalie AriansK LindelJ KrisamK HerfarthD KrugS AkbabaJ Oelmann-AvendanoJ DebusPublished in: Radiation oncology (London, England) (2017)
Registered at https://clinicaltrials.gov , ClinicalTrials.gov Identifier: NCT03184350 , registered 09 June 2017, enrolment of the first participant 19 June 2017.
Keyphrases
- endometrial cancer
- phase ii study
- end stage renal disease
- locally advanced
- ejection fraction
- newly diagnosed
- chronic kidney disease
- early stage
- clinical trial
- open label
- prognostic factors
- patients undergoing
- peritoneal dialysis
- squamous cell carcinoma
- health insurance
- study protocol
- patient reported outcomes
- randomized controlled trial
- placebo controlled